| human | Q5 |
| P7893 | CIÊNCIAVITAE ID | 3E16-21FB-4B19 |
| P6178 | Dimensions author ID | 01362471173.54 |
| P496 | ORCID iD | 0000-0003-3157-7542 |
| P3829 | Publons author ID | 1360003 |
| P1053 | ResearcherID | K-6455-2014 |
| P1153 | Scopus author ID | 55676862500 |
| P69 | educated at | University of Lisbon | Q1122926 |
| Independente University | Q2492346 | ||
| P108 | employer | National Institute of Health Dr. Ricardo Jorge | Q6041414 |
| University of the Basque Country | Q1232428 | ||
| P735 | given name | Ana | Q482671 |
| Ana | Q482671 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q35409900 | Advantages and versatility of fluorescence-based methodology to characterize the functionality of LDLR and class mutation assignment |
| Q61988935 | Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis |
| Q37716374 | Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia. |
| Q50632268 | Cardiovascular risk profile of high school students: a cross-sectional study. |
| Q61988938 | Characterization of the First PCSK9 Gain of Function Homozygote |
| Q38845770 | Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries. |
| Q52804842 | Familial hypercholesterolaemia in Portugal. |
| Q90439216 | Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity |
| Q47893397 | Genetic diagnosis of familial hypercholesterolaemia: the importance of functional analysis of potential splice-site mutations. |
| Q92195954 | Genomics of familial hypercholesterolaemia |
| Q35920600 | Hepatitis B and C prevalence in Portugal: disparity between the general population and high-risk groups. |
| Q44751613 | How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound |
| Q45326595 | Hypercholesterolemia--a disease with expression from childhood. |
| Q51756675 | In vitro functional characterization of missense mutations in the LDLR gene. |
| Q39124388 | Low-density lipoprotein receptor mutational analysis in diagnosis of familial hypercholesterolemia |
| Q50649200 | Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia? |
| Q38801930 | Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry |
| Q48181942 | Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement. |
| Q60310655 | No Evidence for Lower Levels of Serum Vitamin D in the Presence of Hepatic Steatosis. A Study on the Portuguese General Population |
| Q39062979 | Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia |
| Q36353492 | Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity |
| Q92361445 | The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes |
| Q35572016 | The importance of an integrated analysis of clinical, molecular, and functional data for the genetic diagnosis of familial hypercholesterolemia. |
| Q42912037 | Update of the Portuguese Familial Hypercholesterolaemia Study |
Search more.